Maximizing adherence and retention for women living with HIV and their infants in Kenya (MOTIVATE! study): study protocol for a randomized controlled trial
- PMID: 29378622
- PMCID: PMC5789594
- DOI: 10.1186/s13063-018-2464-3
Maximizing adherence and retention for women living with HIV and their infants in Kenya (MOTIVATE! study): study protocol for a randomized controlled trial
Abstract
Background: Successful completion and retention throughout the multi-step cascade of prevention of mother-to-child HIV transmission (PMTCT) remains difficult to achieve. The Mother and Infant Visit Adherence and Treatment Engagement study aims to evaluate the effect of mobile text messaging, community-based mentor mothers (cMMs), or both on increasing antiretroviral therapy (ART) adherence, retention in HIV care, maternal viral load suppression, and mother-to-child HIV transmission for mother-infant pairs receiving lifelong ART.
Methods/design: This study is a cluster randomized, 2 × 2 factorial, controlled trial. The trial will be undertaken in the western Kenyan counties of Migori, Kisumu, and Homa Bay. Study sites will be randomized into one of four groups: six sites will implement both text messaging and cMM, six sites will implement cMM only, six sites will implement text messaging only, and six sites will implement the existing standard of care. The primary analysis will be based on the intention-to-treat principle and will compare maternal ART adherence and maternal retention in care.
Discussion: This study will determine the impact of long-term (up to 12 months postpartum) text messaging and cMMs on retention in and adherence to ART among pregnant and breastfeeding women living with HIV in Kenya. It will address key gaps in our understanding of what interventions may successfully promote long-term retention in the PMTCT cascade of care.
Trial registration: ClinicalTrials.gov, NCT02491177 . Registered on 11 March 2015.
Keywords: Community mentor mothers; HIV; Option B+; PMTCT; SMS; Text messages.
Conflict of interest statement
Ethics approval and consent to participate
Ethical approval for this study has been obtained from the institutional review boards of the University of Colorado Denver, the University of Alabama at Birmingham, and KEMRI. This trial will also be supported by an independent Safety Monitoring Committee. This trial is registered with ClinicalTrials.gov (NCT02491177). Written informed consent is obtained from all participants before study participation.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



References
-
- Joint United Nations Programme on HIV/AIDS . 2015 Progress Report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva: UNAIDS; 2015.
-
- World Health Organization . Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015. - PubMed
-
- Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B + ’) in Malawi. AIDS (London, England) 2014;28(4):589–98. doi: 10.1097/QAD.0000000000000143. - DOI - PMC - PubMed
-
- Chan AK, Kanike E, Bedell R, Mayuni I, Manyera R, Mlotha W, et al. Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi. J Int AIDS Soc. 2016;19(1):20672. doi: 10.7448/IAS.19.1.20672. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical